False-positive and true-negative hilar and mediastinal lymph nodes on FDG-PET: Radiological-pathological correlation

Annals of Nuclear Medicine

Volumn 18, Issue 1, 2004, Pages 23-28

  Shiraki, Norio ^a   Hara, Masaki ^a   Ogino, Hiroyuki ^a   Shibamoto, Yuta ^a   Iida, Akihiko ^b   Tamaki, Tsunco ^c   Murase, Takayuki ^a   Eimoto, Tadaaki ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Nagoya City Rehabilitation and Sports Center Hospital   (Japan)

^c Kaikoukai Nagoya Kyoritsu Hospital   (Japan)

Author keywords

False positive; FDG PET; Hilum; Lymph nodes; Mediastinum

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BIOACCUMULATION; BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; LABORATORY DIAGNOSIS; LYMPHOCYTE; MACROPHAGE; MALE; MEDIASTINUM; MEDIASTINUM LYMPH NODE; MEDICAL ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 1842736053     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02985610     Document Type: Article

References (26)

1. Steinert HC, Hauser M, Allemann F, Engel H, Berthold T, von Schulthess GK, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997; 202: 441-446.
2. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191: 371-377.
3. Scott WJ, Gobar LS, Terry JD, Dewan NA, Sunderland JJ. Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 1996; 111: 642-648.
4. 18F]FDG positron emission tomography (PET). Thorax 1997; 52: 438-441.
5. Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Verschakelen JA, Nackaerts KL, et al. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group. Chest 1997; 112: 1480-1486.
6. Farrell MA, McAdams HP, Herndon JE, Patz EF Jr. Related non-small cell lung cancer: FDG PET for nodal staging in patients with stage 1 disease. Radiology 2000; 215: 886-890.
7. Chin R Jr, Ward R, Keyes JW, Choplin RH, Reed JC, Wallenhaupt S, et al. Mediastinal staging of non-small-cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 1995; 152 (6 Pt 1): 2090-2096.
8. 18FDG in patients with bronchogenic carcinoma. Chest 1995; 108 (6): 1617-1621
9. Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Bogaert J, Maes A, et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998; 16 (6): 2142-2149.
10. Nettelbladt OS, Sundin AE, Valind SO, Gustafsson GR, Lamberg K, Langstrom B, et al. Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum. J Nucl Med 1998; 39: 640-647.
11. Kutlu CA, Pastorino U, Maisey M, Goldstraw P. Selective use of PET scan in the preoperative staging of NSCLC. Lung Cancer 1998; 21 (3): 177-184.
12. Valk PE, Pounds TR, Hopkins DM, Haseman MK, Hofer GA, Greiss HB, et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Am Thorac Surg 1995; 60 (6): 1573-1581.
13. Sazon DA, Santiago SM, Soo Hoo GW, Khonsary A, Brown C, Mandelkern M, et al. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med 1996; 153: 417-421.
14. Schiepers C. Related articles, role of positron emission tomography in the staging of lung cancer. Lung Cancer 1997; 17 (Suppl 1): S29-35.
15. Liewald F, Grosse S, Storck M, Guhlmann A, Halter G, Reske S, et al. How useful is positron emission tomography for lymphnode staging in non-small-cell lung cancer? J Thorac Cardiovasc Surg 2000; 48: 93-96.
16. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999; 19: 61-77.
17. Hara M, Shiraki N, Iida A, Tamaki T, Itoh M, Arakawa T. A problem of FDG-PET in patients with lung cancer diagnosed as N3: False positive. Radiology 2001; 221 (P): 409.
18. Armstrong P. Mediastinum and Hilar Disorders In: Armstrong P, Wilson AG, Dee P, eds. Imaging of Diseases of the Chest, 3rd ed. London: Mosby, 2000: 789-892.
19. Rosai J. Ackerman's Surgical Pathology. 8th ed. St. Louis; Mosby-Year Book, 1996; 2: 1670-1671.
20. Johansson A, Camner P. Are alveolar macrophage translocated to the lymph nodes? Toxicology 1980; 15: 157-162.
21. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Related intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972-1980.
22. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995; 36: 1301-1306.
23. Boisellef PM, Patz EF Jr, Vining DJ, Weissleder R, Shephard JA, McLoud TC. Imaging of mediastinal lymph nodes: CT, MR, and FDG PET. 1998; 18: 1061-1069.
24. Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE. Staging non-small cell lung cancer with whole-body PET. Radiology 1999; 212: 803-809.
25. Lowe VJ, Duhaylongsod, Patz EF, Delong DM, Hoffman JM, Wolfe WG, et al. Pulmonary abnormalities and PET data analysis: A retrospective study. Radiology 1997; 202: 435-439.
26. Inoue K, Matoba S. Counterattack of re-emerging tuberculosis after 38 years. Int J Tuberc Lung Dis 2001; 5: 873-875.